Skip to search formSkip to main contentSkip to account menu

ARC111

Known as: ARC-111 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
To design ARC-111 analogues with improved efficiency, we constructed the QSAR of 22 ARC-111 analogues with RPMI8402 tumor cells… 
2012
2012
ARC-111 has potent topoisomerase I-targeting activity and pronounced antitumor activity. To design ARC-111 analogues with… 
2010
2010
Dibenzo [c,h]-[1,6] naphthyridin-6-one (ARC-111) and its analogues can exhibit potent topoisomerase I targeting and antitumor… 
2008
2008
Topoisomerase I (TopoI), an established anticancer target, is an enzyme producing a single-strand DNA break during transcription… 
2007
2007
ARC-111, a small-molecule topoisomerase I inhibitor, is a potent cytotoxic drug against multiple human cancer cell lines under… 
2006
2006
Proc Amer Assoc Cancer Res, Volume 47, 2006 5540 The hypoxia-inducible factor-1 (HIF-1) transcription factor is an essential… 
Highly Cited
2003
Highly Cited
2003
8,9-Dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6] naphthyridin-6-one (ARC-111, topovale) is a…